Skip to main content
. 2020 May 11;39(2):195–207. doi: 10.5534/wjmh.200014

Table 1. Clinical studies conducted in some dietary components in prostate cancer.

Dietary component Finding Reference
Vitamin E ↓Risk of prostate cancer and aggressive disease [50]
↓PSA serum levels in recurrent prostate cancer patients [51]
Maintain stable disease and median progression-free survival of 2.8 months in patients with castrate-resistant prostate cancer [52]
↑Risk of prostate cancer (>7 times/wk) [53]
↑High-grade of prostate cancer [54]
No effect on prostate cancer and BPH [55,56]
Carotenoids ↑Incidence of prostate cancer (20 mg/d) [60]
Not associated with prostate cancer (30 mg or 50 mg) [61,62]
Not associated with prostate cancer [50]
Vitamin D ↑Prostate cancer in certain subpopula-tions (<20 ng/mL) [65]
↓Aggressive prostate cancer [66]
↓Risk of prostate cancer [67]
↓IL-8 and CRP in patients with prostate cancer
↓CRP in prostate cancer patients [68]
↑Risk of prostate cancer [70]
Zinc ↑4.36-fold of developing fatal prostate cancer [53]
Selenium ↓Prostate cancer susceptibility [72]
↓Risk of aggressive prostate cancer [73]
No effect [74,75]
Flavonoids ↓Prostate cancer [76]
Dietary fiber ↓Total and advanced prostate cancer [77,78,79,80]
No effect [81,82]

PSA: prostate-specific antigen, BPH: benign prostatic hyperplasis, IL: interleukin, CRP: C-reactive protein.